Physician profile
Kenneth A Lee
NPI 1295734960
$95,837.39
in general payments reported to CMS, 2019-2025
29 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $15K · 2021: $7,263 · 2022: $3,730 · 2023: $12K · 2024: $24K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $14K · Education: $8,158 · Honoraria: $5,900 · Food and Beverage: $4,995 · Travel and Lodging: $2,916 · Gift: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,330.00 |
| Consulting Fee | $13,590.50 |
| Education | $8,157.50 |
| Honoraria | $5,900.00 |
| Food and Beverage | $4,995.01 |
| Travel and Lodging | $2,915.78 |
| Gift | $196.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $39,872.08 | 2019-2025 | Tagrisso, Datroway |
| Intuitive Surgical, INC. | $17,482.56 | 2019-2024 | Da Vinci Surgical System |
| Elucent Medical | $13,778.11 | 2023-2025 | |
| Baxter Healthcare | $12,296.61 | 2021-2024 | Coseal, Hemopatch, Peri-Strips Dry |
| Veran Medical Technologies, INC. | $7,509.60 | 2019-2020 | |
| Pulmonx Corporation | $1,278.43 | 2019 | |
| Medtronic, INC. | $970.80 | 2023-2025 | Signia |
| Fujifilm Healthcare Americas Corporation | $366.04 | 2022-2024 | Fujifilm |
| Ethicon US, LLC | $304.52 | 2021-2022 | |
| Galvanize Therapeutics, INC | $297.22 | 2023-2024 | Aliya System |
| Tempus Ai, INC | $266.65 | 2024 | Xt Cdx |
| Caris Mpi, INC. | $266.00 | 2025 | Mi Cancer Seek |
| Davol INC. | $252.03 | 2019-2021 | |
| Angiodynamics, INC. | $216.76 | 2025 | Auryon Laser System 100-120 Vac |
| Ethicon INC. | $156.54 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $88.50 | 2019-2021 | |
| Lilly USA, LLC | $67.98 | 2019-2020 | |
| Becton, Dickinson and Company | $60.11 | 2019 | |
| Merck Sharp & Dohme LLC | $57.15 | 2024-2025 | Keytruda |
| Atricure, INC. | $55.02 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $50.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.74 | 2019 | |
| Biom'Up France Sas | $31.95 | 2021 | |
| Bard Peripheral Vascular, INC. | $22.09 | 2021 | |
| Genzyme Corporation | $17.05 | 2021 | |
| On Target Laboratories, INC | $15.37 | 2025 | Cytalux |
| Myriad Genetic Laboratories, INC. | $13.93 | 2021 | |
| Healthmyne, INC. | $11.21 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.